Teva Announces Chief Medical Officer Transition
Teva disclosed November 18 that Eric Hughes, EVP Global R&D and chief medical officer, intends to leave after accepting an external offer. David Gardiner, head of Innovative Medicines and Clinical Development, immediately became R&D…




